Nalaganje...
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
Tyrosine kinase inhibitors (TKIs) are anticancer drugs with a lesser toxicity than classical chemotherapeutic agents but still with a narrow therapeutic window. While hepatotoxicity is known for most TKIs, underlying mechanisms remain mostly unclear. We therefore aimed at investigating mechanisms of...
Shranjeno v:
| izdano v: | Front Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5469902/ https://ncbi.nlm.nih.gov/pubmed/28659801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00367 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|